Clinical Trial: A Study to Evaluate the Efficacy and Safety of HTMC0658 Tablets in the Treatment of Chronic Rhinosinusitis Without Nasal Polyps

U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07174115) titled 'A Study to Evaluate the Efficacy and Safety of HTMC0658 Tablets in the Treatment of Chronic Rhinosinusitis Without Nasal Polyps' on Sept. 08.

Brief Summary: The purpose of this clinical trial is to assess the efficacy and safety of HTMC0658 tablets in treating subjects with chronic rhinosinusitis without nasal polyps (CRSsNP).

Study Start Date: Aug. 18

Study Type: INTERVENTIONAL

Condition: Chronic Sinusitis Without Nasal Polyps

Intervention: DRUG: HTMC0658

HTMC0658 tablet

Recruitment Status: RECRUITING

Sponsor: Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.

Published by HT Digital Content Services with pe...